Glioma of Brain Clinical Trials
2 recruiting trials for Glioma of Brain. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Glioma of Brain clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1), Universitaire Ziekenhuizen KU Leuven (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Vorasidenib (drug, 1 trial), followed by Radiotherapy, active surveillance.
Track Glioma of Brain trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy...
The study aims to assess the direct patient-reported perception (PROs) of individuals affected by IDH-mutant, grade 2 gliomas undergoing radiotherapy or pharmacological treatment...
Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients
Gliomas are the most common primary intracranial tumors, representing at least 75% of all primary malignant brain tumors. Histopathologically, gliomas are classified into...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Glioma of Brain, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Glioma of Brain, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Glioma of Brain, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.